The worlds first Upadatinib extended-release tablets approved by FDA for non-radiological axial spondyloarthritis 2022-11-02
JAK inhibitor, the successor to Hummero? 2022-11-02
India starts testing a pharmaceuticalcompanys exports of cough syrup 2022-10-24
New regulations on online sales of drugs clarify the management of online sales of prescription drugs 2022-10-20
Flu new drug approved only 1 year, Shi Yao Ou Yi that is the first copy! Roche responds... 2022-10-20
A quarter of a billion dollars! Merck Partners with Moderna to Advance mRNA cancer Vaccine plus K drug for melanoma 2022-10-20
Sodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapySodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapy 2022-10-20
When is "water inverse" going on? Biogens ALS drug approval delayed to next April 2022-10-20
Not as good as a placebo? Relmada Therapeutics Shares plunge 80% after Phase 3 trial of New Drug for Major Depression fails! 2022-10-20
With a second drug in Phase III for Alzheimers, Can Bonjian turn the tide this time? 2022-10-18
From the long-term insulin Icodec phase III study GrSlam, looking at the development history of Novo Nordisk 2022-10-18
With a second drug in Phase III for Alzheimers, Can Bonjian turn the tide this time? 2022-10-18
Semaglutide: Another phenomenon-level new drug, breaking one billion in "seconds", the "weight loss" market is basically out of stock 2022-10-14
Preliminary clinical success of Pfizers oral GLP-1 agonist 2022-09-30
New study shows that daily multivitamins may ameliorate Alzheimers disease 2022-09-30
Market Report of Monoclonal Antibody Drugs in China (2022) 2022-09-20
Chinas National Health Insurance Bureau is studying the inclusion of innovative medical supplies into medical insurance 2022-08-31
FDA approves ibrutinib for chronic graft-versus-host disease in children 1 year older 2022-08-31
First BCMA/CD3 dual antibodies approved by EU 2022-08-31
FDA Approves Bluebird Gene Therapy Zynteglo 2022-08-23
CXO -- Booming industry strong demfor R&D 2022-08-23
Pharmaceutical Equipment - Continued prosperous development, biologics market expansion brings important drivers 2022-08-23
Vaccines - COVID-19 epidemic drives rapid industry development 2022-08-23
Life science reagents - Strong demfor research development, industry favorable policies continue 2022-08-23
FDA Issues Drug Statement, Mercks Hypoglycemic Drug Sitagliptin Detected Potential Carcinogen 2022-08-17
Breaking News! Chinas First KRAS G12D Inhibitor Approved for Clinical Use 2022-08-15
Pfizers $11.6 Billion Double-acting Migraine Drug Generates $318 Million in First-half Revenue 2022-08-09
2022H1: Top 10 Best-Selling Drugs in the World 2022-08-08
Huadong Medicine Liraglutide Injection for Obesity or Overweight Indication Application for Listing 2022-08-03
Upadatinibs launch accelerated: Crohns disease has simultaneously submitted marketing applications in FDA&EMA 2022-08-02
Huadong Medicine Liraglutide Injection for Obesity or Overweight Indication Application for Listing 2022-08-02
AbbVie Ends An Alzheimers Immunotherapy Collaboration with Alector 2022-07-13
共
1508 个 页次:
4 /
48 页
32 个/页
首页 上一页 下一页 尾页
转到:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
Our Advantages of Reports
①All reports written by ourselves ②All data having original sources ③Information is the latest ④Continuous historical data ⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract) ②Transfer payment to company's bank account ③After accepting payment we email the report to clients (PDF format) ④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd ②Beneficiary's Account No.:110060239018002127366 ③Name of bank:Bank of Communications Beijing Branch,Fuwai Sub-Branch ④Address of bank:NO7,FUWAISTREET,XICHENG DISTRICT,BEIJING,CHINA SWIFT CODE:COMMCNSHBJG